Showing results (21-30 of 70) with videos related to

Sort By:
Pageof 7
Frontiers in Immunology|March 21, 2020
Characteristics of Tumor-Infiltrating Lymphocytes Prior to and During Immune Checkpoint Inhibitor TherapyIoana Plesca, Antje Tunger, Luise Müller, et al.
Transplantation|April 23, 2009
Extracorporeal photopheresis efficiently impairs the proinflammatory capacity of human 6-sulfo LacNAc dendritic cellsMichael Gerner, Kristina Hölig, Rebekka Wehner, et al.
Cancer Letters|March 1, 2006
Identification of a naturally processed T cell epitope derived from the glioma-associated protein SOX11Marc Schmitz, Rebekka Wehner, Stefan Stevanovic, et al.
Clinical & Developmental Immunology|November 16, 2010
Dendritic cell-based immunotherapy for prostate cancerHanka Jähnisch, Susanne Füssel, Andrea Kiessling, et al.
Experimental Hematology|August 7, 2012
Differential effects of mixed lymphocyte reaction supernatant on human mesenchymal stromal cellsFrederick Fasslrinner, Manja Wobus, Regina Duryagina, et al.
Experimental Hematology|June 19, 2012
Impact of lenalidomide on the functional properties of human mesenchymal stromal cellsManja Wobus, Gwendolin Benath, Ruben A Ferrer, et al.
Cellular and Molecular Life Sciences : CMLS|March 12, 2025
The DNase TREX1 is a substrate of the intramembrane protease SPP with implications for disease pathogenesisOnur Kerem Tever, Torben Mentrup, Ivan Kingyue Chinn, et al.
Frontiers in Immunology|June 28, 2024
Type I conventional dendritic cells and CD8+ T cells predict favorable clinical outcome of head and neck squamous cell carcinoma patientsJohanna Kirchner, Ioana Plesca, Rebecca Rothe, et al.
Cancer Letters|February 14, 2013
TLR7/8 agonists trigger immunostimulatory properties of human 6-sulfo LacNAc dendritic cellsHanka Jähnisch, Rebekka Wehner, Antje Tunger, et al.
Haematologica|June 24, 2009
Mesenchymal stem cells efficiently inhibit the proinflammatory properties of 6-sulfo LacNAc dendritic cellsRebekka Wehner, Diana Wehrum, Martin Bornhäuser, et al.
Pageof 7